LBM-415

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLBM-415
Drug Alias NameVRC-3375VRC-4307VRC-4887VRC-3324VRC 3852 +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPeptide deformylase inhibitorsCell wall inhibitors
TargetsPeptide deformylase
Therapy Area/IndicationsPneumoniaBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsPneumoniaBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A